The Internet Corporation for Assigned Names and Numbers (ICANN) on Thursday kicked off a new application process for generic ...

Ronald Mann, Justices poised to protect generics manufacturers from liability for decisions of pharmacists about prescribing ...

Overview Java backend roles in 2026 demand strong fundamentals plus expertise in modern frameworks like Spring Boot and ...

The rapid entry of semaglutide generics is beginning to weigh on the growth of Eli Lilly’s tirzepatide brand Mounjaro, even as the broader market expands, data from pharma market intelligence and data ...

LOWERING DRUG COSTS — Bipartisan lawmakers have revived efforts to require Medicare to cover generic drugs — and at least two biosimilars — with patients paying lower costs than for brand-name drugs, ...

The FDA has approved the first generic versions of Farxiga, a drug used to treat Type 2 diabetes and reduce the risk of hospitalization for heart failure. The generic, dapagliflozin, is indicated to ...

US slaps 100% tariffs on patented drugs Tariff exemption for generics shields most Indian drugmakers Sun Pharma faces capped 15% tariffs on innovative products. Did our AI summary help? Indian ...

US President Donald Trump has announced a sweeping 100 per cent tariff on select pharmaceutical imports, a move that comes shortly after a Jefferies report flagged the possibility of such measures, ...

Danish pharmaceutical giant Novo Nordisk on Tuesday announced price cuts of up to 48% on its blockbuster diabetes and obesity drugs Ozempic and Wegovy in India, weeks after semaglutide—the active ...

Patients in Canada have been paying between $300 and $400 a month for Ozempic and Wegovy, depending on the prescribed dose You can save this article by registering for free here. Or sign-in if you ...

The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. A woman removes a ...

The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the green light this weekend to start selling generic versions of Ozempic and Wegovy, with several ...